Cystoid Macular Edema Clinical Trial
Official title:
Incidence of Post-operative Cystoid Macular Edema: A Prospective Study Comparing DMEK, DSEK, and DSO
Verified date | January 2023 |
Source | Wake Forest University Health Sciences |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This study aims to evaluate and compare incidence of post-operative cystoid macular edema (CME) after Descemet Membrane Endothelial Keratoplasty (DMEK), Descemet's Stripping Automated endothelial Keratoplasty (DSEK) and Descemet Stripping Only (DSO).
Status | Terminated |
Enrollment | 4 |
Est. completion date | August 24, 2022 |
Est. primary completion date | August 24, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Any patient that is undergoing DSO or endothelial corneal transplantation vis DMEK or DSEK Exclusion Criteria: - Patients that do not have an optical coherence tomography measurement pre- operatively - Patients that don't have an optical coherence tomography measurement post- operatively - Patients with a previous history of uncontrolled macular edema |
Country | Name | City | State |
---|---|---|---|
United States | Wake Forest Health Sciences | Winston-Salem | North Carolina |
Lead Sponsor | Collaborator |
---|---|
Wake Forest University Health Sciences |
United States,
Arbelaez JG, Price MO, Price FW Jr. Long-term follow-up and complications of stripping descemet membrane without placement of graft in eyes with Fuchs endothelial dystrophy. Cornea. 2014 Dec;33(12):1295-9. doi: 10.1097/ICO.0000000000000270. — View Citation
Inoda S, Hayashi T, Takahashi H, Oyakawa I, Yokogawa H, Kobayashi A, Kato N, Kawashima H. Risk Factors for Cystoid Macular Edema After Descemet Membrane Endothelial Keratoplasty. Cornea. 2019 Jul;38(7):820-824. doi: 10.1097/ICO.0000000000001950. — View Citation
Kocaba V, Mouchel R, Fleury J, Marty AS, Janin-Manificat H, Maucort-Boulch D, Burillon C. Incidence of Cystoid Macular Edema After Descemet Membrane Endothelial Keratoplasty. Cornea. 2018 Mar;37(3):277-282. doi: 10.1097/ICO.0000000000001501. — View Citation
Koenig SB. Planned Descemetorhexis Without Endothelial Keratoplasty in Eyes With Fuchs Corneal Endothelial Dystrophy. Cornea. 2015 Sep;34(9):1149-51. doi: 10.1097/ICO.0000000000000531. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Incidence of Post-Op CME | The frequency (number of Subjects) of post-operative Cystoid Macular Edema will be evaluated for patients receiving DMEK, DSEK or DSO. | 6 weeks post-operative | |
Primary | Incidence of Post-Op CME | The frequency (number of Subjects) of post-operative Cystoid Macular Edema will be evaluated for patients receiving DMEK, DSEK or DSO. | 3 months post-operative | |
Primary | Severity of Post-Op CME | The severity of post-operative Cystoid Macular Edema will be evaluated for patients receiving DMEK, DSEK or DSO that experience Cystoid Macular Edema after surgery - measured by net change of Central Foveal Thickness on Optical Coherence Tomography (OCT- is an imaging technique that uses low-coherence light to capture micrometer-resolution, two- and three-dimensional images from within optical scattering media, e.g., biological tissue) | 6 weeks post-operative | |
Primary | Severity of Post-Op CME | The severity of post-operative Cystoid Macular Edema will be evaluated for patients receiving DMEK, DSEK or DSO that experience Cystoid Macular Edema after surgery - measured by net change of Central Foveal Thickness on Optical Coherence Tomography (OCT- is an imaging technique that uses low-coherence light to capture micrometer-resolution, two- and three-dimensional images from within optical scattering media, e.g., biological tissue) | 3 months post-operative | |
Secondary | Graft Detachment | Frequency (number of Subjects) of post-operative graft detachment will be evaluated in patients that receive a corneal endothelial transplant. | 6 weeks and 3 months post-operative | |
Secondary | Re-bubbling Procedure | The incidence (number of Subjects) of re-bubbling procedures performed post-operatively will be evaluated. | 6 weeks and 3 months post-operative | |
Secondary | Infection | The incidence (number of Subjects) of post-operative infection will be evaluated. | 6 weeks and 3 month post-operative | |
Secondary | Final Visual Acuity | The Snellen Visual Acuity test - This means that the test subject sees the same line of letters at 20 feet that person with normal vision sees at 20 feet. 20/40 vision means that the test subject sees at 20 feet what a person with normal vision sees at 40 feet. | 3 months post-operative |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00508040 -
Evaluation of Birdshot Retine Choroidopathy Treatment by Either Steroid or Interferon alpha2a
|
Phase 2 | |
Terminated |
NCT00114062 -
Study to Treat Uveitis Associated Macular Edema
|
Phase 2 | |
Completed |
NCT03025945 -
Prospective Study With Adjunctive Once Daily Topical Nepafenac 0.3% Versus Placebo
|
N/A | |
Completed |
NCT01978015 -
Blood-aqueous Barrier Changes After the Use of Timolol and Prostaglandin Analogues Fixed Combination in Pseudophakic Patients With POAG
|
Phase 4 | |
Recruiting |
NCT05158699 -
Effectiveness of Periocular Drug Injection in CATaract Surgery
|
Phase 3 | |
Withdrawn |
NCT02598869 -
Posterior Subtenon Versus Intravitreal Injection of Triamcinolone Acetonide for Treatment of Uveitic Cystoid Macular Edema
|
Phase 4 | |
Completed |
NCT02294656 -
Acute Pseudophakic Cystoid Macular Edema Treatment Trial: Intravitreal Ranibizumab Versus Triamcinolone Acetonide
|
Phase 1 | |
Withdrawn |
NCT00406172 -
Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME)
|
Phase 3 | |
Not yet recruiting |
NCT04856670 -
Assessing Diabetes Mellitus on Cytokine Analysis and Macular Edema Following FLACS
|
||
Completed |
NCT02609165 -
Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular Edema
|
Phase 2 | |
Withdrawn |
NCT00438243 -
Pilot Study of the Effect of Topical Bromfenac Ophthalmic Solution 0.09%in Patients With Acute Post-operative Cystoid Macular Edema.
|
Phase 2 | |
Completed |
NCT00464581 -
Lucentis for Treatment of Macular Edema
|
N/A | |
Active, not recruiting |
NCT03465124 -
Evaluation of Central Macular Thickness in Femtosecond Laser-assisted Cataract Surgery
|
N/A | |
Recruiting |
NCT02486484 -
Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection
|
Phase 2 | |
Completed |
NCT00790803 -
Pegaptanib Therapy in Non-Infectious Uveitic Cystoid Macular Edema
|
N/A | |
Recruiting |
NCT04225611 -
Therapeutic Contact Lens Drug Delivery System (TCL-DDS) in Patients With Recurrent Cystoid Macular Edema
|
Phase 1/Phase 2 | |
Completed |
NCT05832996 -
Cool vs Room-temperature Artificial Tears
|
Phase 4 | |
Completed |
NCT05615805 -
The Effect of Ocular Rinse Volume on Surface Irritation After Intravitreal Injections
|
N/A | |
Completed |
NCT00494494 -
Effect of Nepafenac on Post-operative Macular Swelling Following Uncomplicated Cataract Surgery
|
Phase 4 | |
Terminated |
NCT00346983 -
Macugen to Prevent Worsening of Macular Edema Following Cataract Surgery in Diabetics
|
Phase 1/Phase 2 |